Increased risk of developing Crohn’s disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

(2018) Julien Kirchgesner et al.   GASTROENTEROLOGY

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

(2017) Magali Lemaitre et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Characteristics of Skin Lesions Associated With Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease

(2015) Isabelle Cleynen et al.   ANNALS OF INTERNAL MEDICINE

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

(2015) Jens Klotsche et al.   ANNALS OF THE RHEUMATIC DISEASES

Extraintestinal Manifestations of Inflammatory Bowel Disease

(2015) Stephan R. Vavricka et al.   INFLAMMATORY BOWEL DISEASES

Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics

(2015) D. Barthel et al.   JOURNAL OF RHEUMATOLOGY

Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases

(2015) Susana Rodrigues   WORLD JOURNAL OF GASTROENTEROLOGY

The Danish Civil Registration System as a tool in epidemiology

(2014) Morten Schmidt et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis

(2014) Asha Krishnan et al.   RHEUMATOLOGY INTERNATIONAL

Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey

(2013) Raphaèle Seror et al.   RHEUMATOLOGY

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series

(2011) Éric Toussirot et al.   JOINT BONE SPINE

Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept

(2011) T. D. van DIJKEN et al.   JOURNAL OF RHEUMATOLOGY

The Danish National Patient Register

(2011) Elsebeth Lynge et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The Danish Civil Registration System

(2011) Carsten Bøcker Pedersen   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent

(2010) Sreedhar Subramanian et al.   INFLAMMATORY BOWEL DISEASES

Infliximab-related hepatitis: discussion of a case and review of the literature

(2010) Stefano Mancini et al.   Internal and Emergency Medicine

Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study

(2010) A. Dallocchio et al.   RHEUMATOLOGY

Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?

(2009) Sunny Singh et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Psoriasis Induced by Anti-TNF Probably Not So Uncommon

(2009) Rosario Ibáñez Bosch et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES